Skip Nav Destination
Abstract CT173: Sunitinib (S) in patients (pts) with metastatic breast cancer (mBC) with FGFR1 mutations or amplifications: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Cancer Res (2021) 81 (13_Supplement): CT173.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Hyewon Ryu
Journal of the Korean Medical Association (2023) 66 (12): 716.
- I-Wen Song
- Henry Hiep Vo
- Ying-Shiuan Chen
- Mehmet A. Baysal
- Michael Kahle
- Amber Johnson
- Apostolia M. Tsimberidou
Cancers (2023) 15 (7): 1967.